查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589599

透過血腦障壁的藥物輸送市場：按藥物輸送技術、按應用分類 - 全球預測 2025-2030

Drug Delivery Across Blood Brain Barrier Market by Drug Delivery Technology (Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB), Application (Alzheimer's Disease, Brain Cancer, Epilepsy) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血腦障壁給藥市值為6.6715億美元，預計2024年將達到7.2697億美元，複合年成長率為9.06%，預計到2030年將達到12%，預計將達到24.38美元十億。

跨越血腦障壁（BBB）的藥物輸送的範圍和定義包括跨越這種選擇性滲透性屏障輸送治療藥物以治療阿茲海默症、帕金森氏症和腦腫瘤等腦部相關疾病的技術。的方法這種機制至關重要，因為血腦障壁發揮保護大腦免受外來物質侵害的作用，同時防止許多潛在的治療藥物進入中樞神經系統。由於傳統藥物在治療神經系統疾病方面效果有限，因此需要這種傳遞系統，並推動了標靶治療領域的發展。其在製藥和生物技術行業的應用不斷擴大，其中奈米顆粒、脂質體和共軛分子等創新遞送方法的開發發揮重要作用。最終使用者包括需要準確有效治療方法的醫院、研究機構和專科診所。

主要市場統計
基準年[2023] 66715萬美元
預測年份 [2024] 7.2697 億美元
預測年份 [2030] 1,224.38 百萬美元
複合年成長率（%） 9.06%

市場促進因素包括神經系統疾病盛行率的增加、奈米技術的進步以及研發投資的快速增加。研究機構和製藥公司之間的合作旨在創新有效的藥物輸送解決方案並將其商業化，這是一個潛在的商機。但市場面臨監管要求複雜、開發成本高、技術障礙等挑戰。此外，病人安全問題和道德考量構成了主要障礙。該領域的創新可集中於提高治療的生物有效性和特異性、增強非侵入性遞送方法以及探索跨血腦屏障的新型分子轉運機制。

該市場競爭激烈，但探索的時機已經成熟，重點是戰略夥伴關係關係、專利申請和跨學科研究合作以實現突破。最終，持續努力建立強大的臨床試驗和監管框架對於利用市場機會至關重要。追求智慧藥物輸送系統的進步並利用人工智慧主導的平台來實現個人化醫療有可能徹底改變神經系統疾病的治療模式，這是一個備受期待的未來發展領域。

市場動態：快速發展的血腦障壁介導的藥物輸送市場的關鍵市場洞察

供需的動態交互作用正在改變跨血腦障壁的藥物輸送市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 阿茲海默症神經系統疾病的增加
    • 失智症盛行率上升主要影響老年人口
    • 長期照護患者的醫療支出增加
  • 市場限制因素
    • 血腦障壁（BBB）有效限制治療藥物滲入大腦
  • 市場機會
    • 擴大使用奈米技術來治療各種醫療狀況
    • 醫療旅遊業和長期照護設施的成長
    • 加大醫藥研發投入
  • 市場挑戰
    • 與治療藥物相關的嚴重副作用

波特五力：開拓血腦障壁藥物輸送市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對血腦障壁藥物輸送市場的外部影響

外部宏觀環境因素在塑造血腦障壁介導的藥物傳輸市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血腦障壁給藥市場的競爭狀況

對血腦障壁藥物輸送市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣血腦障壁介導的藥物傳輸市場供應商的績效評估

FPNV 定位矩陣是評估血腦障壁藥物輸送市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血腦障壁介導的藥物輸送市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血腦障壁藥物輸送市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 阿茲海默症神經系統疾病的發生率增加
      • 失智症盛行率上升，主要影響老年人口
      • 長期照護患者的醫療費用增加
    • 抑制因素
      • 血腦障壁（BBB）有效限制治療藥物滲入大腦
    • 機會
      • 擴大使用奈米技術來治療各種醫療狀況
      • 不斷發展的醫療旅遊業和長期照護設施
      • 加大醫藥研發投入
    • 任務
      • 與治療藥物相關的嚴重副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血腦障壁給藥市場：透過給藥技術

  • 雙特異性抗體 RMT 方法
  • 被動擴散
  • 血腦屏障滲透性增加
  • 特洛伊木馬的方法

第7章血腦障壁市場：依應用分類

  • 阿茲海默症
  • 腦腫瘤
  • 癲癇
  • 韓特氏症
  • 多發性硬化症
  • 帕金森氏症

第8章美洲血腦障壁藥物輸送市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太血腦障壁給藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的血腦障壁給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • AbbVie Inc.
  • Angiochem Inc.
  • Bioasis Technologies Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Carthera SA
  • CNS Pharmaceuticals, Inc.
  • Cordance Medical Inc.
  • F. Hoffmann-La Roche Ltd.
  • ICON PLC
  • JCR Pharmaceuticals Co., Ltd.
  • Nanoform Finland Oyj
  • Ossianix, Inc.
  • Pfizer Inc.
Product Code: MRR-221461477305

The Drug Delivery Across Blood Brain Barrier Market was valued at USD 667.15 million in 2023, expected to reach USD 726.97 million in 2024, and is projected to grow at a CAGR of 9.06%, to USD 1,224.38 million by 2030.

The scope and definition of drug delivery across the blood-brain barrier (BBB) encompass techniques and technologies focused on delivering therapeutic agents across this selective permeability barrier to target brain-related conditions such as Alzheimer's, Parkinson's, and brain tumors. This mechanism is crucial due to the BBB's role in protecting the brain from foreign substances while concurrently impeding many potential therapeutic agents from entering the CNS. The necessity for such delivery systems arises from the limited efficacy of conventional drugs in treating neurological disorders, thus advancing the field of targeted therapy. Applications extend across pharmaceuticals and biotechnology industries where developing innovative delivery methods, such as nanoparticles, liposomes, and conjugated molecules, play critical roles. End-user segments include hospitals, research institutes, and specialty clinics that require precise and effective treatment options.

KEY MARKET STATISTICS
Base Year [2023] USD 667.15 million
Estimated Year [2024] USD 726.97 million
Forecast Year [2030] USD 1,224.38 million
CAGR (%) 9.06%

Market insights reveal several growth drivers, including increasing prevalence of neurological disorders, advancements in nanotechnology, and a surge in R&D investments. Collaborations between research organizations and pharmaceutical companies present potential opportunities, as industries seek to innovate and commercialize effective drug delivery solutions. However, the market faces challenges such as complex regulatory requirements, high developmental costs, and technological barriers. Additionally, patient safety concerns and ethical considerations also pose significant hurdles. Innovating within this space could focus on improving the bioavailability and specificity of therapeutic agents, enhancing non-invasive delivery methods, and exploring novel molecular transport mechanisms across the BBB.

The nature of the market is competitive yet ripe for exploration, emphasizing strategic partnerships, patent acquisitions, and multidisciplinary research collaborations to achieve breakthroughs. Ultimately, pitching efforts toward building a robust framework for clinical trials and regulatory pathways is vital for capitalizing on market opportunities. Pursuing advancements in smart drug delivery systems and leveraging AI-driven platforms for personalized medicine are highly promising areas for future development, potentially revolutionizing treatment paradigms for neurological conditions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Across Blood Brain Barrier Market

The Drug Delivery Across Blood Brain Barrier Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of neurological disorders, such as Alzheimer's disease
    • Rising prevalence of dementia, majorly affecting the elderly population
    • Rising healthcare expenditure for long term care patients
  • Market Restraints
    • Blood-brain barrier (BBB) efficiently restricts penetration of therapeutic agents to the brain
  • Market Opportunities
    • Increasing the use of nanotechnology in treating various medical conditions
    • Growing medical tourism industry and long-term care facilities
    • Growing investment in pharmaceutical research & development
  • Market Challenges
    • Serious side effects associated with therapeutic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Across Blood Brain Barrier Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Across Blood Brain Barrier Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Across Blood Brain Barrier Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Across Blood Brain Barrier Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Across Blood Brain Barrier Market

A detailed market share analysis in the Drug Delivery Across Blood Brain Barrier Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Across Blood Brain Barrier Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Across Blood Brain Barrier Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Across Blood Brain Barrier Market

A strategic analysis of the Drug Delivery Across Blood Brain Barrier Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Across Blood Brain Barrier Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AbbVie Inc., Angiochem Inc., Bioasis Technologies Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Carthera S.A., CNS Pharmaceuticals, Inc., Cordance Medical Inc., F. Hoffmann-La Roche Ltd., ICON PLC, JCR Pharmaceuticals Co., Ltd., Nanoform Finland Oyj, Ossianix, Inc., and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Across Blood Brain Barrier Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Delivery Technology, market is studied across Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB, and Trojan Horse Approach.
  • Based on Application, market is studied across Alzheimer's Disease, Brain Cancer, Epilepsy, Hunter's Syndrome, Multiple Sclerosis, and Parkinson's Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of neurological disorders, such as Alzheimer's disease
      • 5.1.1.2. Rising prevalence of dementia, majorly affecting the elderly population
      • 5.1.1.3. Rising healthcare expenditure for long term care patients
    • 5.1.2. Restraints
      • 5.1.2.1. Blood-brain barrier (BBB) efficiently restricts penetration of therapeutic agents to the brain
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing the use of nanotechnology in treating various medical conditions
      • 5.1.3.2. Growing medical tourism industry and long-term care facilities
      • 5.1.3.3. Growing investment in pharmaceutical research & development
    • 5.1.4. Challenges
      • 5.1.4.1. Serious side effects associated with therapeutic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Across Blood Brain Barrier Market, by Drug Delivery Technology

  • 6.1. Introduction
  • 6.2. Bispecific Antibody RMT Approach
  • 6.3. Passive Diffusion
  • 6.4. Permeability Increase of BBB
  • 6.5. Trojan Horse Approach

7. Drug Delivery Across Blood Brain Barrier Market, by Application

  • 7.1. Introduction
  • 7.2. Alzheimer's Disease
  • 7.3. Brain Cancer
  • 7.4. Epilepsy
  • 7.5. Hunter's Syndrome
  • 7.6. Multiple Sclerosis
  • 7.7. Parkinson's Disease

8. Americas Drug Delivery Across Blood Brain Barrier Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Drug Delivery Across Blood Brain Barrier Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Drug Delivery Across Blood Brain Barrier Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AbbVie Inc.
  • 3. Angiochem Inc.
  • 4. Bioasis Technologies Inc.
  • 5. Boehringer Ingelheim International GmbH
  • 6. Bristol-Myers Squibb Company
  • 7. Carthera S.A.
  • 8. CNS Pharmaceuticals, Inc.
  • 9. Cordance Medical Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. ICON PLC
  • 12. JCR Pharmaceuticals Co., Ltd.
  • 13. Nanoform Finland Oyj
  • 14. Ossianix, Inc.
  • 15. Pfizer Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY BISPECIFIC ANTIBODY RMT APPROACH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PASSIVE DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PERMEABILITY INCREASE OF BBB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY TROJAN HORSE APPROACH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY HUNTER'S SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET, FPNV POSITIONING MATRIX, 2023